Zou, Chunbo <br/><br/>
Effect of the oral iron chelator deferiprone in diabetic nephropathy rats.  [electronic resource] 

 -  Journal of diabetes  Apr 2017 
 - 332-340 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1753-0407 
<br/><br/><label>Standard No.: </label>10.1111/1753-0407.12420  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Blotting, Western<br/>Chemokine CCL2--genetics<br/>Cyclooxygenase 2--genetics<br/>Deferiprone<br/>Diabetes Mellitus, Experimental--complications<br/>Diabetic Nephropathies--etiology<br/>Dietary Carbohydrates--adverse effects<br/>Dose-Response Relationship, Drug<br/>Gene Expression--drug effects<br/>Immunohistochemistry<br/>Iron Chelating Agents--administration & dosage<br/>Kidney--drug effects<br/>Male<br/>Matrix Metalloproteinase 9--genetics<br/>Microscopy, Electron, Transmission<br/>NF-kappa B--genetics<br/>Protective Agents--administration & dosage<br/>Pyridones--administration & dosage<br/>Random Allocation<br/>Rats<br/>Rats, Wistar<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Tissue Inhibitor of Metalloproteinase-1--genetics<br/>Tyrosine--analogs & derivatives